Skip to main content

The Journal Gazette

Business

Pfizer to buy Array BioPharma in $11.4 billion deal

NEW YORK -- Pfizer is buying the cancer treatment company Array BioPharma in a deal valued at $11.4 billion.

June 17, 2019 7:14 am